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Among other biomedical applications, magnetic nanoparticles and liposomes have a vast ﬁeld of applications in tissue
engineering and regenerative medicine. Magnetic nanoparticles and liposomes, when introduced into cells to be cultured,
maneuver the cell’s positioning by the appropriate use of magnets to create more complex tissue structures than those
that are achieved by conventional culture methods.
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INTRODUCTION
The goal of producing functional tissues is challenged by
the complexity of organ architectures. It is difﬁcult enough
to vascularize tissue constructs, let alone to recapitulate
the complex arrangement of cells and extracellular matrix
found in functional organs. The loss of tissue or the failure
of an organ is a frequent, devastating, and costly prob-
lem in human health care. Tissue engineering (TE) applies
principles of biology and engineering to the development
of functional substitutes of damaged tissue. In general, tis-
sue engineering involves the following processes:1
(a) Target cells are isolated and expanded to the required
cell number;
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(b) Cells are harvested and reseeded into three-
dimensional biodegradable scaffolds, allowing 3D cell cul-
ture; and
(c) The cultured 3D constructs are transplanted into
patients.
In tissue engineering and regenerative medicine
(TERM), production of a scaffold in a mold is an example
of a classical and traditional top-down strategy. A more
interesting and recent bottom-up approach relies on the
self-assembly of a scaffold from smaller components,
potentially with different functionalities designed to carry
out distinct tasks.
A common characteristic of the current bottom-up
strategies for scaffold fabrication is the assembly of
molecules into nanoscale structures, which then assemble
into macroscopic objects. Self-assembling molecules that
form nanoscale structures that then form gels are excellent
examples of bottom-up assembly.2
Although the technology of these processes in tissue
engineering is established, processes can be improved and
optimized for speciﬁc applications. The use of nanotech-
nologies has been employed in all the steps of develop-
ing for tissue engineering strategies.3 In particular, such
methodologies may be used in physical manipulation of
target cells which is essential to advancement in the
ﬁeld of tissue engineering.4 Treatment concepts based on
those techniques would eliminate problems of donor site
scarcity, immune rejection and pathogen transfer.5
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Nano-sized magnetic nanoparticles and liposomes are
increasingly being used across the wide spectrum of the
biomedical ﬁeld including in regenerative medicine. The
ability to control the location of these nanoparticles dis-
tally using magnets, upon functionalization to enable spe-
ciﬁc binding, stands to induce a high concentration in a
given tissue or organ. Research needs to go beyond using
this technique as an investigative tool and should focus
on its potential to actively control cellular processes with
an eye towards clinical applications, in particular in tissue
engineering and regenerative medicine.6
MAGNETIC NANOPARTICLES
AND LIPOSOMES
The application of nanotechnology has opened a new
realm of advancement in the ﬁeld of regenerative medicine
and has provided hope for the culmination of long-felt
needs by the development of an ideal means to control
the biochemical and mechanical microenviroment for suc-
cessful cell delivery and tissue regeneration. Both top-
down and bottom-up approaches have been widely used
in the advancement of this ﬁeld, be it by improvement in
scaffolds for cell growth, development of new and efﬁ-
cient delivery devices, cellular modiﬁcation and tracking
applications or by development of nanodevices such as
biosensors.7
In the rapidly developing areas of nanobiotechnol-
ogy and nanomedicine, magnetic nanoparticles (MNPs)
are one type of the most well-established nanomaterials
because of their biocompatibility and the potential applica-
tions as alternative contrast enhancing agents for magnetic
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resonance imaging (MRI). While developing of MNPs as
alternative contrast agents for MRI application has moved
quickly to testing in animal models and clinical trials,
other applications of biofunctional MNPs, such as manip-
ulating proteins or cells, have been explored extensively
at the stage of qualitative or conceptual demonstration.8
In fact, the response of MNPs to a magnetic ﬁeld offers a
unique way to modulate cellular behavior in a non-contact
or “remote” mode, i.e., the magnet exerts force on the
cells without direct contact. Procedures to produce bio-
functional MNPs have been summarized recently.9–11
The high biocompatibility and versatile nature of lipo-
somes have made these particles keystone components in
many hot-topic biomedical research areas. Liposomes can
be combined with a large variety of nanomaterials, such
as superparamagnetic iron oxide nanoparticles (SPIONs).12
Because the unique features of both the magnetizable col-
loid and the versatile lipid bilayer can be joined, the result-
ing so-called magnetoliposomes can be exploit in a great
array of biotechnological and biomedical applications. For
decades, clinicians have used liposome as nanoscale sys-
tems to deliver encapsulated anthracycline molecules for
cancer treatment. Instead, the more recent proposition to
combine liposomes with nanoparticles remains at the pre-
clinical development stages.13
Magnetic cationic liposomes (MCLs) are cationic self-
assembled lipid vesicles containing 10 nm magnetite
nanoparticles. The cationic surface of MCLs reinforces
the electrostatic interaction between MCLs and target cell
membranes, resulting in the improvement of the accumu-
lation of magnetite nanoparticles in the target cells. In a
typical experimental procedure, the MCLs can be prepared
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from colloidal magnetite (10 nm) and a lipid mixture
consisting of N -(-trimethylammonioacetyl)-didodecyl-
D-glutamate chloride (TMAG), dilauroylphosphatidyl-
choline (DLPC), and dioleoylphosphatidyl-ethanolamine
(DOPE) in a 1:2:2 molar ratio.1 The mean hydrodynamic
size of the magnetic cationic liposomes, determined by
dynamic light scattering, was around 150 nm.14
In tissue engineering, magnetic separation methods have
been employed to isolate target cells in co-culture sys-
tems. In these methods, target cells were co-cultured with
nontarget cells labeled with magnetite cationic liposomes.
Thus, when necessary, the MCL-labeled nontargeted cells
were magnetically removed from the co-culture, result-
ing in negative isolation of the target cells. In these co-
cultures, target cells were separated with 94% purity and
98% recovery yield on average.15 For tissue engineer-
ing purposes, also magnetic nanoparticles and magnetic
force have been used to concentrate the retroviral vec-
tors to enhance the transduction efﬁciency and to enable
their magnetic manipulation. Additionally, the magneti-
cally labeled retroviral vectors can be directed to the
desired regions for infection by applying magnetic ﬁelds,
and micro-patterns of gene-transduced cell regions could
be created on a cellular monolayer using micro-patterned
magnetic concentrators.16
MAGNETS AND MAGNETIC FORCES
The biomedical application of magnetic forces has long
been studied. For example, magnetic resonance imag-
ing is a mainstay of clinical diagnostic radiology, rely-
ing on superconducting magnets and large magnetic
ﬁelds. Magnets have also been used to levitate biologi-
cal samples through the natural diamagnetism of organic
materials. Incorporation of superparamagnetic iron oxide
nanoparticles has further enabled manipulation of sur-
face patterns, contrast-enhanced magnetic resonance imag-
ing, cell sorting, mechanical-conditioning of cells, studies
of mechanic-sensitive membrane properties, and cellular
micromanipulation. SPIONs can also be modiﬁed to tar-
get proteins or can be coupled to cationic liposomes for
delivery and concentration.17
Three different geometries are founded among the mag-
nets used for magnetic force-based tissue engineering and
regenerative medicine: cylindrical, rectangular, and ring
shaped. All of them are permanent magnets consisting of a
Neodymium–Iron–Boron alloy (NdFeB) or an Aluminum–
Nickel–Cobalt alloy (AlNiCo). Developed in the 1980s,
neodymium magnets are the strongest type of permanent
magnets made, producing signiﬁcantly stronger magnetic
ﬁelds than other types (such as AlNiCo magnets). The
magnetic ﬁeld typically produced by NdFeB magnets can
be in excess of 1.3 T, whereas AlNiCo magnets typically
exhibit ﬁelds between 0.5 and 1 T. The magnets were
inserted into a thermo-contractive Teﬂon tube and both
ends of the tube were sealed with a silicone rubber to
avoid oxidizing by the culture medium. The magnets were
sterilized by exposure to ultraviolet (UV) radiation.18
An electromagnet was also used to get a variable mag-
netic ﬁeld by Shimizu et al.19 They obtain a maximum
magnetic ﬁeld intensity of 0.45 T at the tip of the probe
that was controlled by a foot switch.
The spatial distribution of magnetic nanoparticles can
be distally managed by magnetic forces, a unique possi-
bility for the ﬁne control of the position and the activity of
the nanoparticles, and can eventually attach materials with-
out the need of in situ direct manipulation. Such a distant
control permits precise interventions in complex media or
biological systems that could not be reached with alter-
native approaches.20 Magnetic nanoparticles are straight-
forwardly used in magnetic force-based tissue engineering
and regenerative medicine (Mag-TERM), by which it is
possible to deﬁne the position of different cell types in
elaborated tissular structures such as multilayered or tubu-
lar entities.
MAGNETIC FORCE-BASED CELL CULTURE
AND CO-CULTURE TECHNIQUES
Since cells labeled with magnetic nanoparticles (MNPs)
and liposomes (MCLs) can be manipulated using magnets,
a novel tissue engineering methodology using magnetic
force and functionalized magnetic nanoparticles namely,
magnetic force-based tissue engineering (Mag-TE) was
proposed in 2004 by Ito et al.21 They showed that
nanoparticle-labeled endothelial cells maintained their via-
bility and capacity to form a conﬂuent endothelial mono-
layer. Moreover, Mironov et al.22 proposed in 2008 a
deﬁnition of magnetic force-based tissue engineering: the
biofabrication of more complex tissue constructs using
cells, cellular monolayers, and cell aggregates labeled
with magnetic nanoparticles.
Such MCL-labeled cells can be manipulated and orga-
nized by magnetic forces while maintaining their function-
ality (indicating that MCLs are not toxic). In this Mag-TE
approach, a magnet is under the culture plate, attracting
and accumulating magnetically labeled cells.23 This allows
populations of MCL-labeled cells to be sequentially driven
to the surface to create 2D patterned or even 3D multi-
layered structures, as already tested with several cell lines,
including human umbilical vein endothelial cells,24 retinal
pigment epithelial cells,25 and keratinocytes,21 among oth-
ers, with promising results. Mag-TE can be divided into
two processes:
(i) Labeling cells magnetically using magnetic nanoparti-
cles or magnetic cationic liposomes, and
(ii) Manipulating magnetically labeled cells directly using
a magnetic ﬁeld.
MCLs were used to magnetically label human ker-
atinocytes. Ito et al.21 showed that magnetically labeled
keratinocytes were accumulated on the surface of the cul-
ture plate using a magnet, and stratiﬁcation was promoted
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by a magnetic force to form a sheet-like 3D construct.
The addition of MCLs to human keratinocytes resulted
in the rapid uptake of magnetite nanoparticles, and the
amount of MCLs accumulated in the keratinocytes reached
a maximum of 70% of the total added MCLs. Magnetically
labeled keratinocytes were seeded and cultured at room
temperature into 24-well ultra-low-attachment plates, with
a covalently bound Poly(N -isopropylacrylamide) hydro-
gel layer, which is hydrophilic and neutral charged.
A neodymium magnet was placed under the plate. Ker-
atinocytes without MCLs, or with MCLs in the absence
of a magnet, did not attach onto the plates. In contrast, in
the presence of the magnet, the keratinocytes with MCLs
accumulated evenly throughout the wells.26
Ito et al.21 also investigated the procedure for har-
vesting keratinocyte sheets constructed by Mag-TE. The
magnet positioned at the reverse side of the plate was
removed. Then, a hydrophilic-treated polyvinylidene ﬂuo-
ride (PVDF) membrane was placed on the top of a cylin-
drical magnet, and the ensemble was positioned on the top
interface of the culture medium with the air. Due to the
magnetic force, the keratinocyte sheets ﬂoated up to the
surface of the culture medium without disruption and stuck
to the PVDF membrane.
Furthermore, Mag-TE permitted to fabricate and harvest
cell sheets that contained HepG2 as a hepatocyte model
or NIH3T3 cells as a stromal ﬁbroblast model, as well
as heterotypic, layered co-cultures containing different cell
lines, as rat hepatocytes and human aortic endothelial cells
(HAECs), providing a proof-of-concept for the applicabil-
ity of this approach for generating complex heterogeneous
tissues.27 Moreover, tubular structures (for example, uri-
nary tissue formed by urothelial cells, smooth muscle cells,
and ﬁbroblasts) can also be created using the Mag-TE pro-
tocol. In this approach, magnetically labeled cells formed
a cell sheet onto which a cylindrical magnet was rolled,
which was removed after the tubular structure had been
formed28 (Fig. 1).
Also, angiogenic cell sheets were fabricated using
a combination of two magnetic force-based techniques:
magnetofection and magnetic cell accumulation. A retro-
viral vector encoding an expression cassette of vascular
endothelial growth factor (VEGF) was labeled with MCLs,
to magnetically attract the particles onto a monolayer
of mouse myoblast C2C12 cells. MCL-mediated infec-
tion increased transduction efﬁciency by 6.7 times. Dur-
ing the fabrication of the tissue constructs, MCL-labeled
cells were accumulated in the presence of a magnetic ﬁeld
to promote the spontaneous formation of a multilayered
cell sheet. VEGF gene-engineered C2C12 (C2C12/VEGF)
cell sheets, constructed using both magnetic force-based
techniques, were subcutaneously transplanted into nude
mice. Histological analyses revealed that on day 14 the
C2C12/VEGF cell sheet grafts had produced thick tissues,
with a high-cell density, and promoted vascularization.29
Figure 1. Tubular structures can be generated by folding
preformed cell layers, obtained around rod-shaped magnets.
Such tubular constructs are recovered after removal of the
magnet.
Ito et al.4 extended the Mag-TE technique towards 3D;
in this case a magnetic force was used to precisely place
magnetically labeled cells onto target cells and to promote
heterotypic cell–cell adhesion to form a three-dimensional
construct. Human aortic endothelial cells were magneti-
cally labeled using MCLs, and the labeled HAECs were
positioned onto a rat hepatocyte layer using a magnetic
force. When a magnet was placed under the culture plate,
HAECs accumulated on the hepatocyte monolayer that
expressed albumin under thick HAECs layers. In the pres-
ence of a magnetic force, layered co-cultures maintained
a high level of albumin secretion throughout the study.30
Using Mag-TE techniques, Ino et al.29 successfully fab-
ricated skin-like structures of transgene-expressing ﬁbrob-
lasts and keratinocytes, which indicates that MCLs are
a potent biomanipulation tool for 3D tissue construction.
Mag-TE was applied for construction of 3D multilay-
ered cell sheets without scaffolds. The cells, magnetically
labeled with MCLs, are seeded onto ultra-low-attachment
dishes. Subsequently, a magnet is placed under the dishes
to accumulate the magnetically labeled cells, and then
3D multilayered cell sheets were constructed.29 This tech-
nology permitted to construct small diameter vascular
tubes consisting of hetorotypic layers of endothelial cells,
smooth muscle cells and ﬁbroblast.22 Mag-TE technique
can be applied to construct a vascularized Normal Human
Dermal Fibroblast (NHDF) sheets incorporating perycites
or smooth muscle cells for vascular stabilization after
transplantation.22
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Mag-TE has already been applied to bone tissue engi-
neering: Bone Marrow Stromal Cell (BMSC) sheets with-
out any scaffolds were constructed and transplanted into
a rat cranial bone defect, enhancing new bone formation
at the defect.14 Also, Mag-TE was applied to bone tissue
engineering using 3D scaffolds. It was also shown that
Mag-TE is suitable for the fabrication of skeletal muscle
tissue due to characteristics such as scaffold-free tissue
engineering, high cell density, and freedom as to the size
and shape of the tissue to be fabricated.
Magnetic Cell Patterning
Manipulation of cell patterns in three dimensions in a man-
ner that mimics natural tissue organization and function
is critical for cell biological studies and likely essential
for successfully regenerating tissues—especially cells with
high physiological demands, such as those of the heart,
liver, lungs, and articular cartilage.31 Although recent
progress in surface chemistry has enabled the spatial con-
trol of cell adhesion onto substrates, conventional methods
usually require specialized devices and time-consuming
processes to fabricate the substrate. For instance, cell-
patterning of mouse ﬁbroblast NIH3T3 cells on a mono-
layer of HaCaT cells was successfully achieved using
poly(ethyelene glycol) to vary the hydrophilicity of the
culture substrate and magnetic forces.32
Alternatively, Ino et al.3324 developed a novel cell-
patterning procedure using magnetic cationic liposomes
which were designed to improve the accumulation of
the 10 nm magnetic nanoparticles into target cells for
magnetic cell manipulation. The MCL-labeled cells could
be micro-patterned using magnetic ﬁeld concentrators,
in which magnetized micron-thick steel plates were
embedded. On the other hand, as the scaffold-free 3D tis-
sue construction approach, multilayered cell sheets were
also created by strongly depositing MCL-labeled cells on
the culture surfaces by magnetic force. In principle, using
the magnetic cell manipulation technique, cell patterns can
be created irrespective of surface conditions. By manipu-
lating the strength, shape, and orientation of the magnetic
ﬁeld, multi-directional cell arrangements can be produced
in vitro and even directly in vivo.34
Akiyama et al.35 applied a magnetic force-based tissue
engineering technique to cardiac tissue fabrication. A mix-
ture of extracellular matrix precursor and cardiomyocytes
labeled with magnetic nanoparticles was added into a well
containing a central polycarbonate cylinder. With the use
of a magnet, the cells were attracted to the bottom of
the well and allowed to form a cell layer. During culti-
vation, the cell layer shrank towards the cylinder, leading
to the formation of a ring-shaped tissue that possessed a
multilayered cell structure and contractile properties. The
major advantage of the Mag-TE technique is the induction
of cell-dense tissues mimicking native tissues, as demon-
strated in the fabrication of cardiomyocyte,40 myoblast cell
sheets36 and muscle tissues.34
Okochi et al.37 fabricated a 3D cell patterning culture
system using an external magnetic force and a pin holder,
which enables the assembly of the magnetically labeded
cells on the collagen gel-coated surface as array-like cell
patterns, resulting in the development of a 3D in vivo cul-
ture model. The cells embedded in type I collagen showed
a compacted, spheroid like conﬁguration at each spot, and
distinct, accelerated cell growth was observed in cancer
model cells compared with control cells. The developed
3D cell culture array was applied to the susceptibility assay
of the GM6001 matrix metalloproteinase (MMP) inhibitor,
a collagenase inhibitor; a distinct suppression of cell pro-
liferation was observed, while little change was observed
in 2D.
Ino et al.38 also have developed single cell culture arrays
using the same procedure. The pin holder was made from
magnetic soft iron and contained more than 6000 pillars
on its surface. The pin holder was placed on a magnet
to concentrate the magnetic ﬂux density above the pillars.
NIH3T3 ﬁbroblasts that were labeled with MCLs were
seeded into a culture dish, and the dish was placed over
the pin holder with the magnet. The magnetically labeled
cells were guided on the surface where the pillars were
positioned and allocated on the arrays with a high resolu-
tion. Single-cell patterning was achieved by adjusting the
number of cells seeded, and the target cell was collected
by a micromanipulator after removing the pin holder with
the magnet. Okochi et al.39 have fabricated a 3D mul-
ti ellular tumor spheroid culture array using a magnetic
force-based cell patterning method, analyzing the effect of
stromal ﬁbroblast on the invasive capacity of melanoma.
Magnetic Cell Seeding
Cell seeding is the ﬁrst step in constructing 3D tissue-like
structures. Although high density cell seeding into scaf-
folds enhances 3D tissue formation (i.e., cartilage, bone,
and cardiac tissue), effective and high-density cell seed-
ing into scaffolds is difﬁcult to achieve. Technical difﬁ-
culties in cell seeding are caused by the insufﬁcient and
inhomogeneous migration of the cells into the overall scaf-
fold volume due to the tortuous path of the interconnected
porous structure and by the loss of culture medium with
cells out of the scaffold. This prolongs the culture period
because of the shortage of initially seeded cells. Therefore,
numerous methodologies for effective cell seeding into 3D
scaffolds have been investigated, but novel techniques are
also required.
In conventional cell seeding (static-seeding), the cell sus-
pension is seeded into small scaffolds using small volumes
of highly concentrated cell suspension. The inevitable prob-
lem is that the seeded cell suspension ﬂows away with the
medium and few cells remain in the scaffolds40 (Fig. 2(a)).
The use of magnetic forces can facilitate cell seeding
into the deep internal space of scaffolds, resulting in higher
scaffold-seeding efﬁciencies. The magnetic force could
attract the magnetically labeled cells to prevent them from
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(a)
(b)
Figure 2. Scheme presenting the cell seeding process of a
scaffold placed at the center of a culture plate. A magnet
was placed on the reverse side of the plate and magnetically
labeled cells were seeded onto the scaffold. The cells were
attracted by the magnetic force, resulting in a high cell seed-
ing efﬁciency and high cell density scaffold (b), whereas only
a low efﬁciency and a low density were achieved when no
magnet was placed (a).
ﬂowing away40 (Fig. 2(b)). It was shown that magnetic
forces dramatically accelerated cell seeding, cell adhesion,
and monolayer assembly.22
It has been widely recognized that cells are seeded onto
only the superﬁcial layer of three-dimensional scaffolds
in tissue engineering technology. To solve this issue, an
effective cell seeding technique into the central part of 3D
scaffolds is required. Sasaki et al.41 developed magnetic
nanoparticles coated with chitosan for enhancing cellu-
lar invasion using magnetic force. Cell-invasion efﬁciency
was enhanced by introducing MNPs into cells and by the
presence of magnetic force. The invasion efﬁcacy depends
on the intensity of the magnetic force. Matrix metallopro-
teinases and adhesion molecules that were upregulated in
response to the attached nanoparticles and exposure to a
magnetic force, may also play a crucial role in improv-
ing cell-invasive ability in this system. This current sys-
tem can efﬁciently enhance cell seeding into the depth of
the scaffold, increase subsequent cell–cell interactions and
shorten the period of cell proliferation.42 This technology
seems to be a useful and effective strategy for vascular and
bone tissue engineering.4 However, its application in vivo
should be examined further before clinical applications,
especially in terms of safety issues.
Magnetic Cell Levitation
Souza et al.18 proposed a three-dimensional tissue culture
based on magnetic levitation of cells in the presence of
a hydrogel base of ﬁlamentous bacteriophase containing
gold nanoparticles (Au NPs) and superparamagnetic iron
oxide nanoparticles. By spatially controlling the magnetic
ﬁeld, the geometry of the cell mass can be manipulated,
and multicellular clustering of different cell types in co-
culture can be achieved. The methodology is based on
the cellular uptake and subsequent magnetic levitation of
a bioinorganic hydrogel. Incorporation of SPIONs creates
a new material that retains the biocompatibility of gold-
phage hydrogels while adding capabilities for the culture
and magnetic manipulation of cells (Fig. 3).
The technology reported provides an alternative to the
use of biodegradable porous scaffolds and protein matri-
ces. This methodology is cost effective, because it does
not require a speciﬁc medium, and it is compatible with
standard 2D cell culture techniques. In fact, magneti-
cally levitated human glioblastoma cells showed similar
pro e n expression proﬁles to those observed in human
tumour xenografts. Control of culture shape, and the abil-
ity to bring cultures together for controlled interaction in
a confrontation assay with in situ monitoring, has been
demonstrated.43 This simple, ﬂexible and effective mag-
netic cell levitation technology may be suitable for a range
of applications in biotechnology, stem cell research, and
regenerative medicine. Indeed, a potential long-term goal
(a) (b)
Figure 3. Magnetic iron oxide containing hydrogels (a) and
human glioblastoma cells treated with magnetic iron oxide-
containig hydrogel held at the air-medium interface by a
magnet (b).
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is the possibility of accomplishing the engineering of nor-
mal tissues or complex organs.
The magnetic cell levitation method, which has been
explored by Nano3D Biosciences (Boston, USA) in the
form of the Bio-Assembler™ devices, provides the advan-
tages of 3D cell culturing in a platform that is no
more complicated than standard 2D culturing. The Bio-
Assembler™ uses biocompatible polymer-based reagents to
deliver magnetic nanoparticles to individual cells so that
an applied magnetic ﬁeld can levitate cells off the bot-
tom of the culture dish and bring cells together near the
air-liquid interface. This initiates cell–cell interactions in
the absence of any artiﬁcial surface or matrix. Magnetic
ﬁelds are designed to rapidly form 3D multicellular struc-
tures in as little as a few hours, including expression of
extracellular matrix proteins, which is must faster than any
other 3D cell culture technique. The morphology, protein
expression, and response to exogenous agents of resulting
tissue show great similarity to in vivo results.43
All cell types that have been tested with the Bio-
Assembler™ have been cultured successfully, including
human cell lines (glioblastomas, astrocytes, ﬁbroblasts,
adipocytes, and endothelial cells), stem cells (murine neu-
ral, mesenchymal, and dental pulp stem cells), and primary
cells (endothelial, smooth muscle, epithelial, ﬁbroblasts,
chondrocytes, and cells isolated from adipose tissue).
We thought that the xample of the commercialized Bio-
Assembler™ system is perhaps the most compelling a d
intriguing of those presented. Nowadays only a few exam-
ples of applications where it has been tested, particularly
in vivo, can be found in the scientiﬁc literature, enlight-
ening and providing strong support for the potential util-
ity of magnetic cultures and cellular structures. Daquinag
et al.44 used a 3D levitation tissue culture system based on
magnetic nanoparticle assembly to model white adipose
tissue development and growth in organoids termed adi-
posheres. They showed that 3T3-L1 preadipocytes remain
viable in spheroids for a long period of time, while in
2D culture, they lose adherence and die after reaching
conﬂuence. Upon adipogenesis induction in 3T3-L1 adi-
pospheres, cells efﬁciently formed larger lipid droplets
typical of white adipocytes in vivo, while only smaller
lipid droplet formation is achievable in 2D. Lee et al.45
demonstrated that hydroxyapatite could selectively be dis-
tinguished from various calcium salts in human aortic
smooth muscle cells in vitro and in calciﬁed cardiovascular
tissues, carotid endarterectomy samples and aortic valves,
ex vivo, by only evaluating, at an early stage, the miner-
alization process induced by external stimuli, osteogenic
factors and a magnetic suspension cell culture.
CONCLUDING REMARKS
The future of cell culturing for biomedical applications
lies in the creation of multicellular structure and organiza-
tion in three dimensions. Many schemes for 3D culturing
are being developed or marketed, such as bio-reactors or
protein-based gel environments, but they suffer from high
cost, low throughput, poor scalability, complexity, or the
presence of non-human biological factors that can alter cell
behavior and preclude therapeutic uses.
However, the labeling of mammalian cells with mag-
netic nanoparticles allows the fabrication of complex tis-
sues that are not achievable by conventional cell culture
and co-culture, such as 2D and 3D cell layers, tubular tis-
sues, or ordered 3D assemblies consisting of several cell
types. The proven lack of toxicity of MNPs and their pro-
gressive development into in vivo applications is expected
to provide exciting tools in the near future for in situ
manipulations, in which cells could be magnetically dis-
tributed for precise tissue engineering.
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